Completed NA INTERVENTIONAL 5-arm NCT02664012

Comparison of Nicotine Plasma Concentrations and Subjective Effects for Three Menthol Electronic Cigarettes vs Combustible Menthol Cigarettes and Nicotine Gum

A Single-Center, Randomized, Open-Label, Crossover Study to Assess Elements of Abuse Liability for Three Menthol Electronic Cigarettes

Sponsor: Celerion

Conditions Smoking

Interventions Electronic Menthol Cigarette #1 Electronic Menthol Cigarette #2 Electronic Menthol Cigarette #3 Leading U.S. Nicotine Gum Own Brand Menthol Cigarette

Updated 7 times since 2017 Last updated: May 31, 2018 Started: Jan 31, 2016 Primary completion: May 31, 2016 Completion: May 31, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Smoking and is currently completed. Celerion leads this study, which shows 7 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jul 2018 — Jan 2021 [monthly]

Completed NA
Jun 2018 — Jul 2018 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jan 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Celerion
R.J. Reynolds Vapor Company
RAI Services Company

Data source: R.J. Reynolds Vapor Company

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lincoln, United States